| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C275-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2007-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a01b63e9f6435a01f7b41f20ecc0cc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18aff2ee161cddcd1322c8cd3e1691b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4e5dcfde81881c4bc9816c425f0c66f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3daa249d9cac46dbabeeb1f7d0f88624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a950d44091fbf176f9ba8cfadde47576 |
| publicationDate |
2009-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090034969-A |
| titleOfInvention |
Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cifiti-inhibitors |
| abstract |
The present invention provides a new class of compounds capable of inhibiting carnitine palmitoyl transferase (CPT) having the general formula (I). The invention also relates to pharmaceutical compositions comprising at least one novel compound according to the invention, and to the therapeutic use of such compounds in the treatment of hyperglycemic conditions such as diabetes and pathologies associated with such conditions, such as congestive heart failure and obesity. It is about. |
| priorityDate |
2006-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |